Storgard Chris 4
4 · Design Therapeutics, Inc. · Filed May 23, 2025
Insider Transaction Report
Form 4
Storgard Chris
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2025-05-01+400,000→ 400,000 totalExercise: $4.71Exp: 2035-04-30→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest as follows: 25% of the shares will vest on April 16, 2026 and the balance of the shares will vest in equal monthly installments thereafter over the following 36 months.